Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology ...

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales of $104.5 million and $400.0 million for full year 2025; ...

Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics Olga Anczukow, Ph.D. Olga Anczukow, Ph.D.

Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...

Companies advance plans for global system architecture and shared infrastructure for Direct-to-Device and other Advanced ...

Swiss Aerospace manufacturer, Pilatus Aircraft Ltd, selects RDU-3068 as PFD/MFD for its basic training aircraft This ...

Q4 2025 Earnings Call March 2, 2026 3:30 AM ESTCompany ParticipantsStefan Borgas - CEO & Executive DirectorIan Botha - ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2025 and ...

NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this ...

NINGBO, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global healthcare ...

MINNETONKA, MN – February 26, 2026 – PRESSADVANTAGE – ...

(Nasdaq: ADMA) ("ADMA" or the "Company"), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced its ...